P. Foa

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari et al. · Annals of Oncology · 2017 · 204 citations

Medicine, Oncology, Radiation Oncology +15

Rabbit antithymocyte globulin (r‐ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy

E. Di Bona, Francesco Rodeghiero, Benedetto Bruno et al. · British Journal of Haematology · 1999 · 163 citations

Medicine, Hematology, Pharmacology +14

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

Armando Santoro, Vittorio Gebbia, Tiziana Pressiani et al. · Annals of Oncology · 2014 · 117 citations · Full text

Medicine, Oncology, Pharmacology +10

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

Sara Lonardi, Alberto Sobrero, Gerardo Rosati et al. · Annals of Oncology · 2016 · 56 citations · Full text

Medicine, Oncology, Chemotherapy +14